These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
371 related items for PubMed ID: 30303592
21. Enhanced GABAergic network and receptor function in pediatric cortical dysplasia Type IIB compared with Tuberous Sclerosis Complex. Cepeda C, André VM, Hauptman JS, Yamazaki I, Huynh MN, Chang JW, Chen JY, Fisher RS, Vinters HV, Levine MS, Mathern GW. Neurobiol Dis; 2012 Jan; 45(1):310-21. PubMed ID: 21889982 [Abstract] [Full Text] [Related]
27. mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis. Yasin SA, Ali AM, Tata M, Picker SR, Anderson GW, Latimer-Bowman E, Nicholson SL, Harkness W, Cross JH, Paine SM, Jacques TS. Acta Neuropathol; 2013 Aug 19; 126(2):207-18. PubMed ID: 23728790 [Abstract] [Full Text] [Related]
28. Phosphorylation of S6 Protein as a Potential Biomarker in Surgically Treated Refractory Epilepsy. Chodraui FI, Garcia CAB, Mendes ND, Santos MV, Beggiora PS, Silva SC, Teixeira TL, da Silva Lopes L, Saggioro FP, Neder L, Machado HR. Dev Neurosci; 2020 Aug 19; 42(5-6):230-236. PubMed ID: 33706310 [Abstract] [Full Text] [Related]
29. Changes in vascular density in resected tissue of 97 patients with mild malformation of cortical development, focal cortical dysplasia or TSC-related cortical tubers. Veersema TJ, de Neef A, van Scheppingen J, Ferrier CH, van Eijsden P, Gosselaar PH, van Rijen PC, Spliet WGM, Braun KPJ, Mühlebner A, Aronica E. Int J Dev Neurosci; 2019 Dec 19; 79():96-104. PubMed ID: 31770571 [Abstract] [Full Text] [Related]
32. Immunohistochemical expression of fibroblast growth factor (FGF)-2 in epilepsy-associated malformations of cortical development (MCDs). Sugiura C, Miyata H, Ueda M, Ohama E, Vinters HV, Ohno K. Neuropathology; 2008 Aug 19; 28(4):372-81. PubMed ID: 18179408 [Abstract] [Full Text] [Related]
37. Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers. Toering ST, Boer K, de Groot M, Troost D, Heimans JJ, Spliet WG, van Rijen PC, Jansen FE, Gorter JA, Reijneveld JC, Aronica E. Epilepsia; 2009 Jun 19; 50(6):1409-18. PubMed ID: 19220410 [Abstract] [Full Text] [Related]
38. Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis. Lee WS, Baldassari S, Stephenson SEM, Lockhart PJ, Baulac S, Leventer RJ. Int J Mol Sci; 2022 Jan 25; 23(3):. PubMed ID: 35163267 [Abstract] [Full Text] [Related]
39. Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb. Shu HF, Zhang CQ, Yin Q, An N, Liu SY, Yang H. J Neuropathol Exp Neurol; 2010 Aug 25; 69(8):838-49. PubMed ID: 20613633 [Abstract] [Full Text] [Related]